Generative AI could boost biopharma R&D productivity by billions, according to McKinsey

[Image credit: Seventyfour/Adobe Stock]

Generative AI stands to add trillions of dollars of value to the world economy, according to a recent McKinsey report. The consultancy noted that about three-quarters of the value of generative AI spans four areas — customer operations, marketing and sales, software engineering and R&D. The latter could see a 12% annual lift in global functional spending as a result of generative AI, representing an approximately $328 billion windfall annually.

An evolution or revolution: UBS and McKinsey’s take on generative AI in biopharma

The investment bank UBS recently reached more muted conclusions, noting that generative AI would represent more of an evolution than a revolution for biopharma.

Conversely, McKinsey bets the technology could deliver productivity gains that account for 10% to 15% of overall R&D costs. This potential largely stems from the applicatio…

Read more
  • 0